CME Group exec granted 2,592 restricted shares

A senior CME Group executive received a new restricted stock grant while surrendering shares back to the company to cover tax withholding on vested awards.

Rhea-AI Filing Summary

CME GROUP INC. (CME) reported that Timothy Francis McCourt, Sr MD Global Head Equity & FX, received an award of 2,592 shares of Class A common stock on September 15, 2026 as a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments subject to continued service. In connection with the vesting of previously granted restricted stock, a total of 1,334 shares were surrendered to the issuer on September 15–16, 2026 to satisfy tax withholding obligations, at reference prices of $275.09 and $272.46 per share. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider McCourt Timothy Francis

Role Sr MD Global Head Equity & FX

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock Class A F2	364	$272.46	$99K
Grant/Award	Common Stock Class A F1	2,592	$275.09	$713K
Tax Withholding	Common Stock Class A F2	302	$275.09	$83K
Tax Withholding	Common Stock Class A F2	330	$275.09	$91K
Tax Withholding	Common Stock Class A F2	338	$275.09	$93K

Holdings After Transaction: Common Stock Class A — 13,366 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
2. F2. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Key Figures

Restricted stock granted: 2,592 shares Shares surrendered for tax withholding: 1,334 shares Reference price September 15 transactions: $275.09 per share +2 more

5 metrics

Restricted stock granted 2,592 shares Grant of CME Class A common stock on September 15, 2026

Shares surrendered for tax withholding 1,334 shares Total Form 4 code F transactions on September 15–16, 2026

Reference price September 15 transactions $275.09 per share Code A grant and code F surrenders on September 15, 2026

Reference price September 16 transaction $272.46 per share Code F surrender on September 16, 2026

Number of tax-withholding transactions 4 transactions Form 4 code F entries related to tax withholding obligations

Key Terms

restricted stock, CME Group Omnibus Stock Plan, tax withholding obligations, Rule 10b5-1

4 terms

restricted stock financial

"Represents a grant of restricted stock under the CME Group Omnibus Stock Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

CME Group Omnibus Stock Plan financial

"grant of restricted stock under the CME Group Omnibus Stock Plan"

tax withholding obligations financial

"satisfy tax withholding obligations in connection with the vesting of restricted stock"

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did the CME (CME) executive receive in this Form 4?

Timothy Francis McCourt received a grant of 2,592 shares of CME Class A common stock on September 15, 2026 as restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments subject to continued service.

How many CME (CME) shares were used to cover tax withholding?

A total of 1,334 shares of CME Class A common stock were surrendered to CME Group to satisfy tax withholding obligations related to the vesting of previously granted restricted stock, through four Form 4 transactions on September 15–16, 2026.

Were the CME (CME) share dispositions open-market sales?

No. The Form 4 states the dispositions with code F represent shares surrendered to the issuer to satisfy tax withholding obligations in connection with restricted stock vesting, not open-market sales.

At what prices were the CME (CME) tax-withholding shares valued?

The surrendered shares were valued at $275.09 per share for the September 15, 2026 transactions and $272.46 per share for the September 16, 2026 transaction, as reported in the Form 4 data.

Was a Rule 10b5-1 trading plan involved in these CME (CME) transactions?

No. The Form 4 indicates no Rule 10b5-1 plan for these transactions; they consist of a restricted stock grant and shares surrendered to the issuer for tax withholding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:25 PM Accepted by SEC EDGAR 09/17/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCourt Timothy Francis

(Last) (First) (Middle)

20 S WACKER DRIVE

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr MD Global Head Equity & FX

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Class A	09/15/2026		A(1)		2,592	A	$275.09	14,700	D
Common Stock Class A	09/15/2026		F(2)		302	D	$275.09	14,398	D
Common Stock Class A	09/15/2026		F(2)		330	D	$275.09	14,068	D
Common Stock Class A	09/15/2026		F(2)		338	D	$275.09	13,730	D
Common Stock Class A	09/16/2026		F(2)		364	D	$272.46	13,366	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

2. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for Timothy Francis McCourt	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)